A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.

Current efforts to improve muscle performance are focused on muscle trophism via inhibition of the myostatin pathway: however they have been unsuccessful in the clinic to date. In this study, a novel protein has been created by combining the soluble activin receptor, a strong myostatin inhibitor, to...

Full description

Bibliographic Details
Main Authors: Marina Boido, Olena Butenko, Consuelo Filippo, Roberta Schellino, Jan W Vrijbloed, Ruggero G Fariello, Alessandro Vercelli
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0228653
id doaj-806d02b576494fb286821db5fb75f973
record_format Article
spelling doaj-806d02b576494fb286821db5fb75f9732021-03-03T21:35:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01153e022865310.1371/journal.pone.0228653A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.Marina BoidoOlena ButenkoConsuelo FilippoRoberta SchellinoJan W VrijbloedRuggero G FarielloAlessandro VercelliCurrent efforts to improve muscle performance are focused on muscle trophism via inhibition of the myostatin pathway: however they have been unsuccessful in the clinic to date. In this study, a novel protein has been created by combining the soluble activin receptor, a strong myostatin inhibitor, to the C-terminal agrin nLG3 domain (ActR-Fc-nLG3) involved in the development and maintenance of neuromuscular junctions. Both domains are connected via the constant region of an Igg1 monoclonal antibody. Surprisingly, young male mice treated with ActR-Fc-nLG3 showed a remarkably increased endurance in the rotarod test, significantly longer than the single domain compounds ActR-Fc and Fc-nLG3 treated animals. This increase in endurance was accompanied by only a moderate increase in body weights and wet muscle weights of ActR-Fc-nLG3 treated animals and were lower than expected. The myostatin inhibitor ActR-Fc induced, as expected, a highly significant increase in body and muscle weights compared to control animals and ActR-Fc-nLG3 treated animals. Moreover, the prolonged endurance effect was not observed when ActR-Fc and Fc-nLG3 were dosed simultaneously as a mixture and the body and muscle weights of these animals were very similar to ActR-Fc treated animals, indicating that both domains need to be on one molecule. Muscle morphology induced by ActR-Fc-nLG3 did not appear to be changed however, close examination of the neuromuscular junction showed significantly increased acetylcholine receptor surface area for ActR-Fc-nLG3 treated animals compared to controls. This result is consistent with published observations that endurance training in rats increased acetylcholine receptor quantity at neuromuscular junctions and provide evidence that improving nerve-muscle interaction could be an important factor for sustaining long term muscle activity.https://doi.org/10.1371/journal.pone.0228653
collection DOAJ
language English
format Article
sources DOAJ
author Marina Boido
Olena Butenko
Consuelo Filippo
Roberta Schellino
Jan W Vrijbloed
Ruggero G Fariello
Alessandro Vercelli
spellingShingle Marina Boido
Olena Butenko
Consuelo Filippo
Roberta Schellino
Jan W Vrijbloed
Ruggero G Fariello
Alessandro Vercelli
A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
PLoS ONE
author_facet Marina Boido
Olena Butenko
Consuelo Filippo
Roberta Schellino
Jan W Vrijbloed
Ruggero G Fariello
Alessandro Vercelli
author_sort Marina Boido
title A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
title_short A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
title_full A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
title_fullStr A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
title_full_unstemmed A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
title_sort new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description Current efforts to improve muscle performance are focused on muscle trophism via inhibition of the myostatin pathway: however they have been unsuccessful in the clinic to date. In this study, a novel protein has been created by combining the soluble activin receptor, a strong myostatin inhibitor, to the C-terminal agrin nLG3 domain (ActR-Fc-nLG3) involved in the development and maintenance of neuromuscular junctions. Both domains are connected via the constant region of an Igg1 monoclonal antibody. Surprisingly, young male mice treated with ActR-Fc-nLG3 showed a remarkably increased endurance in the rotarod test, significantly longer than the single domain compounds ActR-Fc and Fc-nLG3 treated animals. This increase in endurance was accompanied by only a moderate increase in body weights and wet muscle weights of ActR-Fc-nLG3 treated animals and were lower than expected. The myostatin inhibitor ActR-Fc induced, as expected, a highly significant increase in body and muscle weights compared to control animals and ActR-Fc-nLG3 treated animals. Moreover, the prolonged endurance effect was not observed when ActR-Fc and Fc-nLG3 were dosed simultaneously as a mixture and the body and muscle weights of these animals were very similar to ActR-Fc treated animals, indicating that both domains need to be on one molecule. Muscle morphology induced by ActR-Fc-nLG3 did not appear to be changed however, close examination of the neuromuscular junction showed significantly increased acetylcholine receptor surface area for ActR-Fc-nLG3 treated animals compared to controls. This result is consistent with published observations that endurance training in rats increased acetylcholine receptor quantity at neuromuscular junctions and provide evidence that improving nerve-muscle interaction could be an important factor for sustaining long term muscle activity.
url https://doi.org/10.1371/journal.pone.0228653
work_keys_str_mv AT marinaboido anewproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT olenabutenko anewproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT consuelofilippo anewproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT robertaschellino anewproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT janwvrijbloed anewproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT ruggerogfariello anewproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT alessandrovercelli anewproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT marinaboido newproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT olenabutenko newproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT consuelofilippo newproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT robertaschellino newproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT janwvrijbloed newproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT ruggerogfariello newproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
AT alessandrovercelli newproteincurbsthehypertrophiceffectofmyostatininhibitionaddingremarkableendurancetomotorperformanceinmice
_version_ 1714816146096521216